- 全部删除
 
您的购物车当前为空
SB 243213 是一种可口服且具有选择性的 5-HT2C 受体拮抗剂。SB 243213 具有抗焦虑抗抑郁活性,可用于精神分裂症和运动障碍。

SB 243213 是一种可口服且具有选择性的 5-HT2C 受体拮抗剂。SB 243213 具有抗焦虑抗抑郁活性,可用于精神分裂症和运动障碍。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 315  | In stock | |
| 5 mg | ¥ 745  | In stock | |
| 10 mg | ¥ 1,230  | In stock | |
| 25 mg | ¥ 2,880  | In stock | |
| 50 mg | ¥ 4,180  | In stock | |
| 100 mg | ¥ 5,970  | In stock | |
| 200 mg | ¥ 7,880  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 818  | In stock | 
SB 243213 相关产品
| 产品描述 | SB 243213 is an orally available and selective 5-HT2C receptor antagonist.SB 243213 has anxiolytic and antidepressant activity and is used in schizophrenia and movement disorders.  | 
| 靶点活性 |  5-HT2A receptor (human):7.01 (pKi), 5-HT1B receptor (human):5.5 (pKi), 5-HT6 receptor (human):6.5 (pKi), 5-HT1F Receptor (human):5.35 (pKi), 5-HT1D receptor (human):6.32 (pKi), 5-HT7 receptor (human):5.64 (pKi), 5-HT1A receptor (human):<5.3 (pKi), 5-HT2C receptor (human):9.37 (pKi), 5-HT2B receptor (human):7.2 (pKi), 5-HT1E Receptor (human):<5.4 (pKi)  | 
| 体外活性 | SB243213 对克隆的人类 5-HT1D、5-HT1A、5-HT1B、5-HT1E、5-HT1F和 5-HT7 受体显示出较低的亲和力[1]。  | 
| 体内活性 | 在体重为 220-300 克的雄性斯普拉格-道利实验性原生大鼠中,SB 243213(0.1, 0.3, 1, 3, 10 mg/kg;口服;测试前1小时)能够剂量依赖性地显著增加大鼠在明亮条件下和在陌生测试箱中进行社交互动的时间,持续15分钟[1]。  | 
| 分子量 | 428.41 | 
| 分子式 | C22H19F3N4O2 | 
| CAS No. | 200940-22-3 | 
| Smiles | Cc1cc2CCN(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2cc1C(F)(F)F | 
| 密度 | no data available | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (233.42 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容